Webinar: Different Affiliate-Based Outsourcing Models for Regulatory Affairs
Often questions arise about the Affiliate-Based Outsourcing (ABO) Models for Regulatory Affairs:
1. How can it fit your specific needs?
2. How can it adapt to your organization and setup?
3. What are its possibilities of adjusting to your portfolio?
The purpose of this webinar is to share insights on the Regulatory Affairs Affiliate-Based Outsourcing Model’s flexibility and practical tips on how it can be tailored to your needs. We will share examples of different scenarios on how the ABO model can be customized to optimize costs and efficiently manage your local regulatory operations.
Expanding across Europe?
Make use of our experience. Explore your options in an informal chat with one of our experts.
This webinar focuses on learning:
- What are the options for the Affiliate-Based Outsourcing Model for Regulatory Affairs.
- What are the benefits of different models.
- What are the common challenges and how to overcome them.
- How to select the most beneficial Affiliate-Based Outsourcing Model for you.
Duration: 30 minutes
Speaker: Head of Regulatory Affairs, Olga Bernardova.
Olga Bernardova
Head of Regulatory Affairs
Other content that might interest you:
Medical Device Registration in Russia. Challenges and Issues
Webinar: Medical Device Registration in Russia. Challenges and Issues The purpose of this webinar is to show the differences and specifics of regulations and law processes that can cause challenges in medical device registration in Russia. You will learn about:...
eCTD Submission Strategies: In-house vs. Outsourcing
Webinar: eCTD Submission Different Strategies: In-house vs. Outsourcing eCTD Submission Strategies, including outsourcing, are influenced by varying requirements in various regions and countries. That and diverse technical resources by companies often lead to various...
Drugs serialization and barcoding in Saudi Arabia and MENA region
An increasing number of countries worldwide have enacted regulations mandating serialization, tracking and tracing of pharmaceutical products down the supply chain during recent years as a response to drug integrity concerns. There are plenty of laws requiring...
